PRME - Stifel cuts Prime Medicine to hold cites quieter catalyst outlook
2024-01-16 15:41:17 ET
More on Prime Medicine
- Prime Medicine GAAP EPS of -$0.55 misses by $0.07
- Gene editing stocks gain after Eli Lilly deal amid FDA AdCom
- Seeking Alpha’s Quant Rating on Prime Medicine
- Historical earnings data for Prime Medicine
- Financial information for Prime Medicine
For further details see:
Stifel cuts Prime Medicine to hold, cites quieter catalyst outlook